Vol. I  ·  No. 57
Wednesday, November 18, 2026
🔍 Search  ·  278 stories in the archive

Front page › Health › Nov 15, 2026

advisory Ebola disease (Bundibugyo virus) outbreakDemocratic Republic of the Congo · Kenya · NigeriaDRC: 10,920 confirmed cases, 5,323 deaths as of Nov 8 (DRC INSP via ECDC); Kenya 9 cases, 2 deaths; Nigeria 1 casechecked Nov 15

This is news, reported from the sources linked below. Details can change as a story develops; updates and corrections are dated on the story. Full notice.

Six Months In, Congo's Ebola Outbreak Is Still Out of Control

More than 10,900 confirmed cases and about 5,300 deaths make it the deadliest outbreak in Congo's history, and there is still no licensed vaccine for the Bundibugyo strain behind it.

Six months after it was declared in mid-May, the Ebola outbreak in the Democratic Republic of the Congo is still spreading faster than responders can track it, the Associated Press reported Sunday from Bunia. Government data put the number of recorded cases above 11,000, with nearly half of those infected having died, making it the deadliest of Congo's 17 Ebola outbreaks.

The European Centre for Disease Prevention and Control's latest update, citing Congo's national public health institute, counted 10,920 confirmed cases and 5,323 deaths as of Nov. 8. The virus has reached eight of Congo's 26 provinces, with most cases in Ituri and North Kivu. Kenya has confirmed nine cases and two deaths, and Nigeria one case, a patient who was medically evacuated to Switzerland in October.

Africa CDC says about 80% of new cases are being found outside the surveillance system, the AP reported, and about a third of deaths happen at home or elsewhere in the community rather than in treatment centers, a sign the virus is moving unseen. UNICEF figures cited by the AP show children made up 35% of recorded deaths through Nov. 4. Doctors Without Borders has described "a troubling disconnect" between the resources raised for the response and the results.

The outbreak is caused by the Bundibugyo species of Ebola virus, for which no vaccine or specific treatment is licensed. The ECDC says WHO advisers have suggested using Merck's Ervebo, licensed for the Zaire species, mainly within research protocols; Congo began giving it to frontline workers in August, and a Phase 2/3 trial opened in Bunia on Oct. 23. Experts told the AP there is little chance of bringing the outbreak under control within the next year.

The ECDC rates the risk to travelers and to the general population in Europe as low to very low. U.S. travelers should check the CDC's travel health notices before going to the affected areas.

Sources

Around the table

Corrections, questions and better ways to do it are welcome. No stock tips, no referral links, no selling. Nothing here is individual advice, and neither is anything in the comments. Comments are public and kept until you ask us to remove them.